A Silent Mimic: Biopsy-Proven Focal Nodular Hyperplasia Masquerading as Chronic Intrahepatic Biliary Obstruction

Focal nodular hyperplasia (FNH) is a benign hepatic lesion that is typically asymptomatic and most often found incidentally. Biliary obstruction caused by FNH is rare and can create diagnostic uncertainty, particularly when imaging can mimic vascular lesions, hepatocellular adenoma, bile duct adenoma, or congenital hepatobiliary abnormalities. We present the case of a 38-year-old woman with hypertension who was noted to have persistently abnormal liver enzymes on routine outpatient blood tests. She denied symptoms such as jaundice, pruritus, pale stools, dark urine, weight loss, nausea, vomiting, or abdominal pain. Laboratory tests showed a chronic cholestatic-predominant pattern with elevated alkaline phosphatase, mildly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), fluctuating hyperbilirubinemia, and markedly elevated gamma-glutamyl transferase (GGT). Ultrasound revealed intrahepatic biliary ductal dilatation and indeterminate cystic areas within the liver. Computed tomography revealed chronic biliary ductal dilatation, hepatic parenchymal deformity, a mass-like hypertrophied hepatic segment, and a central arterial-enhancing structure initially concerning for aneurysm or pseudoaneurysm. Magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatography (MRCP) demonstrated marked intrahepatic biliary dilatation, an arterially enhancing lesion suspicious for atypical FNH, and a second exophytic lesion causing mass effect on the biliary tree. Differentials included atypical adenoma, intrahepatic bile duct adenoma, vascular lesion, or congenital anomaly. Because serial imaging remained indeterminate, percutaneous liver biopsy was performed. Histopathology showed preserved lobular architecture, intermittent thin fibrous septa, focal sinusoidal dilatation, ductular reaction, and map-like glutamine synthetase staining with membranous beta-catenin staining, supporting the diagnosis of FNH. This case highlights an atypical presentation of FNH causing chronic intrahepatic biliary obstruction and emphasizes the importance of integrating imaging, multidisciplinary review, and histopathology when benign hepatic lesions present atypically and influence management decisions.

Authors

Institutions

Publication Details

Journal
Journal of Medical Cases
Published
2026-09-04
DOI
https://doi.org/10.14740/jmc5364
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Silent Mimic: Biopsy-Proven Focal Nodular Hyperplasia Masquerading as Chronic Intrahepatic Biliary Obstruction

Usama Sakhawat, Ahmed Shehadah, Ali Marhaba, IMROZ APON et al.
Journal of Medical Cases
Cholangiocarcinoma and Gallbladder Cancer Studies
article

A Silent Mimic: Biopsy-Proven Focal Nodular Hyperplasia Masquerading as Chronic Intrahepatic Biliary Obstruction

Usama Sakhawat, Ahmed Shehadah, Ali Marhaba, IMROZ APON, Chibuike Enwereuzo, Behrawar Ahmed
article en

Abstract

Focal nodular hyperplasia (FNH) is a benign hepatic lesion that is typically asymptomatic and most often found incidentally. Biliary obstruction caused by FNH is rare and can create diagnostic uncertainty, particularly when imaging can mimic vascular lesions, hepatocellular adenoma, bile duct adenoma, or congenital hepatobiliary abnormalities. We present the case of a 38-year-old woman with hypertension who was noted to have persistently abnormal liver enzymes on routine outpatient blood tests. She denied symptoms such as jaundice, pruritus, pale stools, dark urine, weight loss, nausea, vomiting, or abdominal pain. Laboratory tests showed a chronic cholestatic-predominant pattern with elevated alkaline phosphatase, mildly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), fluctuating hyperbilirubinemia, and markedly elevated gamma-glutamyl transferase (GGT). Ultrasound revealed intrahepatic biliary ductal dilatation and indeterminate cystic areas within the liver. Computed tomography revealed chronic biliary ductal dilatation, hepatic parenchymal deformity, a mass-like hypertrophied hepatic segment, and a central arterial-enhancing structure initially concerning for aneurysm or pseudoaneurysm. Magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatography (MRCP) demonstrated marked intrahepatic biliary dilatation, an arterially enhancing lesion suspicious for atypical FNH, and a second exophytic lesion causing mass effect on the biliary tree. Differentials included atypical adenoma, intrahepatic bile duct adenoma, vascular lesion, or congenital anomaly. Because serial imaging remained indeterminate, percutaneous liver biopsy was performed. Histopathology showed preserved lobular architecture, intermittent thin fibrous septa, focal sinusoidal dilatation, ductular reaction, and map-like glutamine synthetase staining with membranous beta-catenin staining, supporting the diagnosis of FNH. This case highlights an atypical presentation of FNH causing chronic intrahepatic biliary obstruction and emphasizes the importance of integrating imaging, multidisciplinary review, and histopathology when benign hepatic lesions present atypically and influence management decisions.

Journal of Medical CasesVol. 17(10)
United Health Services (US)
Good health and well-being
Openalex Percentile: Top 8%
Cholangiocarcinoma and Gallbladder Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.